Product image of Minorga (Minoxidil) supplied by GNH India

Minorga

Active Ingredient:
Minoxidil
Origin:
EU

Minorga (Minoxidil)

Minoxidil, the active ingredient in Minorga, is a potassium channel opener presented as a topical solution for topical use. It is indicated for the treatment of androgenetic alopecia, commonly known as pattern hair loss, in both men and women and is widely used under medical supervision.

GNH India supplies Minorga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide globally.

Manufacturer / TM Owner

Laboratoires Bailleul S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minorga (minoxidil) acts on the hair growth cycle to treat androgenetic alopecia, the most common form of pattern hair loss.

  • Androgenetic alopecia in men: promotes regrowth of scalp hair and helps maintain existing hair density.
  • Androgenetic alopecia in women: encourages new hair growth and reduces thinning on the crown and frontal scalp.

How It Works

  • Minoxidil opens ATP‑sensitive potassium channels in dermal papilla cells, leading to hyperpolarization and vasodilation of the scalp microvasculature. The increased blood flow delivers nutrients and oxygen to hair follicles, while the prolonged anagen phase stimulates follicular cell proliferation, resulting in enhanced hair shaft production and reduced follicular miniaturisation. Additionally, minoxidil may up‑regulate vascular endothelial growth factor (VEGF) expression, further supporting follicle health.

Side Effects

Topical minoxidil can cause a range of local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Scalp irritation: redness, itching, or burning sensation at the application site.
  • Dryness or flaking: increased scalp dryness leading to dandruff‑like scaling.
  • Unwanted facial hair growth: fine hair may appear on adjacent skin.
  • Hypertrichosis: excessive hair growth on the treated area.

Serious or Rare Side Effects

  • Allergic reaction: rash, swelling, or hives indicating hypersensitivity.
  • Cardiovascular effects: rapid heartbeat, chest pain, or hypotension.
  • Severe dermatitis: intense inflammation or blistering of the scalp.

Precautions & Warnings

Before using Minorga, consider the following safety measures to minimise risks and ensure appropriate use.

  • Medical evaluation: obtain a professional assessment to confirm diagnosis of androgenetic alopecia.
  • Pregnancy and lactation: avoid use unless a healthcare provider determines benefits outweigh potential risks.
  • Scalp conditions: do not apply on inflamed, infected, or wounded skin.
  • Concomitant medications: inform the prescriber of any topical or systemic vasodilators.
  • Store at room temperature: keep the product in its original container, protect from moisture and direct sunlight.

Avoid Interactions

Minorga may interact with certain systemic and topical agents; awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid)

  • Oral vasodilators: concurrent use can cause additive blood pressure lowering and dizziness.
  • Beta‑blockers: may enhance cardiovascular side effects such as bradycardia.

Moderate Interactions (Monitor Closely)

  • Topical steroids: may reduce minoxidil absorption and effectiveness.
  • Hair dyes or chemical treatments: could alter scalp permeability and affect drug action.
  • Alcohol consumption: may increase scalp irritation and dryness.

Frequently Asked Questions

Minorga contains minoxidil, a topical treatment indicated for androgenetic alopecia, also known as pattern hair loss, in both men and women. It works by stimulating hair follicles to promote regrowth and to slow further thinning of the scalp hair.

Minoxidil acts as a potassium channel opener, causing vasodilation of scalp blood vessels and prolonging the anagen (growth) phase of hair follicles. This increased blood flow and extended growth period help stimulate new hair shaft production and reduce follicular miniaturisation.

The appropriate dose of Minorga is determined by a qualified healthcare professional based on the individual’s condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not alter the amount or frequency without medical advice.

Safety data for minoxidil use in pregnancy or while breastfeeding are limited. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks with their healthcare provider before starting Minorga.

To order Minorga, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

The primary alternative to topical minoxidil is oral finasteride, a 5‑alpha‑reductase inhibitor. While finasteride works systemically to reduce dihydrotestosterone levels, minoxidil acts locally on scalp blood flow and follicle cycling. Choice between them depends on patient preference, gender, side‑effect profile and physician recommendation.

Store Minorga at room temperature, ideally below 25 °C, in its original container. Keep the product away from excessive moisture, direct sunlight and heat sources. Ensure the cap is tightly closed after each use to maintain stability.

Minorga is applied topically to a clean, dry scalp. The prescribed amount is usually spread evenly over the affected areas using the supplied applicator or dropper, and allowed to dry completely before styling or using other hair products. Follow the prescriber’s frequency guidelines.

Serious risks, though rare, include allergic reactions such as rash, swelling or hives, and cardiovascular effects like rapid heartbeat, chest pain or significant drops in blood pressure. If any of these symptoms occur, discontinue use and seek immediate medical attention.

Minorga should be avoided by individuals with known hypersensitivity to minoxidil or any formulation components, those with active scalp infections, severe skin irritation, or open wounds at the application site, and by patients for whom a healthcare professional determines the risks outweigh the benefits.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Minoxidil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT